RxDoctor Payments Data

Harshit Khara, MD

Gastroenterology · Danville, PANPI 1972713147

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Boston Scientific at 51.7% of the total. Among gastroenterology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$438,476in general payments, 2019–2025

Across 552 payments — averaging $794.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$226K
  • Olympus America Inc.$44K
  • Conmed Corporation$42K
  • Olympus Corporation Of The Americas$30K
  • Medtronic$23K
  • Wilson Cook Medical Incorporated$23K
  • plus $52K from 18 others
$17,895in research payments, 2019–2025

Across 2 payments — averaging $8947.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gyrus ACMI, Inc.$18K

What the payments were for

  • Consulting fees$152,39235%
  • Speaking & faculty fees$191,13044%
  • Travel & lodging$57,26713%
  • Food & beverage$13,8693%
  • Education$23,8195%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$438,476 in reported general payments places this provider in the 95th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$20,226
Medicare patients
119
Services billed
201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate20$708

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Danville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →